New drug trial offers hope for rare kidney disease patients
NCT ID NCT06989359
Summary
This study is testing an experimental drug called ADX-038 for adults with specific immune-related kidney diseases. Researchers want to see if the drug is safe and effective at controlling these conditions. The trial will enroll 45 participants who have been diagnosed with diseases like IgA nephropathy or C3 glomerulopathy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGAN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ADARx Clinical Site
RECRUITINGShreveport, Louisiana, 71101, United States
-
ADARx Clinical Site
RECRUITINGShelby, Michigan, 48066, United States
-
ADARx Clinical Site
RECRUITINGDakota Dunes, South Dakota, 57049, United States
-
ADARx Clinical Site
RECRUITINGDallas, Texas, 75230, United States
-
ADARx Clinical Site
RECRUITINGHouston, Texas, 77027, United States
-
ADARx Clinical Site
RECRUITINGWollongong, New South Wales, 2500, Australia
-
ADARx Clinical Site
RECRUITINGPok Fu Lam, 2500, Hong Kong
-
ADARx Clinical Site
RECRUITINGShatin, Hong Kong
-
ADARx Clinical Site
RECRUITINGGyeonggi-do, New South Wales, 05278, South Korea
-
ADARx Clinical Site
RECRUITINGSeoul, New South Wales, 03080, South Korea
-
ADARx Clinical Site
RECRUITINGCheonan, 31151, South Korea
-
ADARx Clinical Site
RECRUITINGSeoul, 03722, South Korea
Conditions
Explore the condition pages connected to this study.